People
Silence Therapeutics, PLC is pleased to announce that further to the announcements on 18 July 2019 detailing the Company’s collaboration with and equity investment by Mallinckrodt plc, Steven Romano, MD, has joined the Board of Silence as a Non-Executive Director.
A recent study published in the American Journal of Human Genetics found that female scientists asked fewer questions than expected at scientific conferences. It doesn’t appear to have much to do with the percentage of women in the sciences, but something cultural or internal.
The Tribune India has recently announced that the Department of Biotechnology will be training “unemployed youth in tools and techniques in the area of biotechnology within a period of three years.”
Taking over the reins of the company will be Vertex’s Chief Medical Officer Reshma Kewalramani. She will assume the role of president and CEO and also take a seat on the board of directors, Vertex announced.
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced that Andrew Howden has been elected as non-executive Chairman of the Board.
Biotech and pharma companies bolster their executive leadership and boards of directors with this week’s appointments.
Arcis Biotechnology, the nucleic acid sample preparation solution provider, announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors.
Renowned Cancer Researcher to Support Ongoing Clinical Studies to Further Demonstrate the Safety and Efficacy of NAD+
MetrioPharm AG, a pharmaceutical development company, welcomes Sven Zimmermann, as its new Chief Financial Officer, bringing more than a decade of experience in strategic transactions.
InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer’s, CTE and other related Dementias.
PRESS RELEASES